NASDAQ
Botanix Pharmaceuticals Limited (BXPHF) has a free cash flow growth of 32.33% as of Friday, May 29, 2026. This represents a 118.61% increase compared to its 12-month average of -173.70%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.